Effects of tamoxifen and exemestane on cognitive functioning: a study in postmenopausal breast cancer patients

Thesis

Cover

Title pages

Table of contents

Chapter 1: General introduction

Chapter 2: The influence of endocrine treatment for postmenopausal breast cancer on cognitive functioning: a review of the literature

Chapter 3: The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy

Chapter 4: Cognitive functioning of postmenopausal breast cancer patients before adjuvant systemic therapy, and its association with medical and psychological factors

Chapter 5: Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal breast cancer patients: results from the neuropsychological side study of the Tamoxifen and Exemestane Adjuvant Multinational (TEAM) trial

Chapter 6: Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM side study

Chapter 7: Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side study

Chapter 8: Summary of results and general discussion

Samenvatting (Dutch summary)

Dankwoord (Acknowledgements in Dutch)

About the author